Close Menu

NEW YORK – Sysmex announced today that it has obtained manufacturing and marketing approval from the Japanese Ministry of Health, Labor, and Welfare for its OncoBEAM RAS Colorectal Kit which tests for mutations in the RAS gene in blood-based circulating tumor DNA (ctDNA) for late-stage CRC patients.

Sysmex believes that physicians can use the assay to help determine whether to use anti-EGFR drugs during treatment.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
16
Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.